Clinical Trial Detail

NCT ID NCT02448173
Title A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements no
Sponsors Vaccinogen Inc
Indications

colon cancer

Therapies
Age Groups: senior adult

No variant requirements are available.